SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-19-000099
Filing Date
2019-11-21
Accepted
2019-11-21 17:11:39
Documents
8
Period of Report
2019-11-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-ktransactionannouncemen.htm 8-K 40536
2 EXHIBIT 1.1 exhibit11_underwritingagre.htm EX-1.1 374616
3 EXHIBIT 5.1 exhibit51_opinionofhoganlo.htm EX-5.1 13561
4 EXHIBIT 99.1 exhibit991_424b5pressrelea.htm EX-99.1 11232
5 EXHIBIT 99.2 exhibit992_424b5pressrelea.htm EX-99.2 12538
6 hoganlogoa03.jpg GRAPHIC 8798
7 optinoselogorgb.jpg GRAPHIC 10067
8 optinoselogorgba11.jpg GRAPHIC 10067
  Complete submission text file 0001494650-19-000099.txt   493869
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 191238052
SIC: 2834 Pharmaceutical Preparations